middle.news
How MVP’s Penthrox Growth Offsets EBIT Loss Amid FX Headwinds
9:04am on Thursday 19th of February, 2026 AEDT
•
Healthcare
Read Story
How MVP’s Penthrox Growth Offsets EBIT Loss Amid FX Headwinds
9:04am on Thursday 19th of February, 2026 AEDT
Key Points
Group revenue rises 8% to $21.6 million
Pain Management segment up 18%, led by Penthrox volume growth
EBIT records a $0.3 million loss, excluding FX impact shows improvement
Positive operating cashflow of $0.3 million, up $1.0 million year-on-year
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MEDICAL DEVELOPMENTS INTERNATIONAL (ASX:MVP)
OPEN ARTICLE